DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Anne de Boer :

Anne de Boer

University of Groningen

Paper: Factors affecting DPI development from bench to bedside

Download Presentation PDF

Anne Haaije de Boer is a process engineer by training and started his career in the Department of Pharmaceutical Technology and Biopharmacy of the Groningen University (NL) in 1973 where he was research leader of the inhalation group from June 1985 till November 2015. His interest is in powder formulation for inhalation, inhaler device development and aerosol characterisation. He developed the basic concepts for the Novolizer® (Meda) and Genuair® (AstraZeneca) multi-dose DPI’s, and a novel disposable dry powder inhaler platform (Twincer®) for high dose antibiotic, vaccine and protein delivery, all having air classifier technology for effective powder dispersion. The Twincer® has recently been taken into production for the administration of colistimethate sodium and a second-generation device (Cyclops) is currently in development for aminoglycosides in tuberculosis therapy and levodopa against off-periods in Parkinson’s disease. He and his co-workers also designed an inhaler adapter for aerosol characterisation with laser diffraction technique (Sympatec) and contributed to the understanding of the variables and mechanisms involved in particle interactions and powder dispersion. Anne Haaije de Boer retired on November 1st 2015, but he stays connected with the university in Groningen in order to further develop the Twincer® disposable high dose dry powder inhaler platform.

Photos of Anne de Boer

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk